
|Videos|September 15, 2021
Dr. Kaufman hails autologous muscle-derived cells as "transformational" SUI treatment
Author(s)Urology Times staff
“This technology is truly a transformational opportunity for urology,” says Melissa R. Kaufman, MD, PhD, FACS.
Advertisement
In this video, Melissa R. Kaufman, MD, PhD, FACS, discusses autologous muscle derived cells for urinary sphincter repair (AMDC-USR) and how this technology is designed to treat stress urinary incontinence (SUI) in female patients. Kaufman is a professor of urology and chief of the division of reconstructive urology and pelvic health at Vanderbilt University, Nashville, Tennessee.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Mohit Khera, MD, recaps key takeaways from FDA panel on TRT for men
2
FDA approves first-line Zenflow system for the treatment of BPH
3
FDA approves niraparib plus abiraterone acetate with prednisone for BRCA2+ mCSPC
4
FDA approves zoliflodacin for uncomplicated urogenital gonorrhea
5

















